Patent · US Expired

System, apparatus and method for inferring glucose levels within the peritoneum with implantable sensors

US7228160B2 · kind B2 · utility

7Cited by
7References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 6, 2003
Grant dateJun 5, 2007
Priority date
Expiry dateFeb 25, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/54
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A glucose sensor assembly useful in patient systems includes an oxygen sensor from which glucose levels in the vicinity of the peritoneal cavity may be inferred. The sensor assembly may be associated with electronics, such as any or all of a DC power supply, an LED source of blue light, a photoreceptor for red light, a CPU, and transceiver, by a direct percutaneous connection. Alternatively they may be associated transdermally with the sensor and some of the electronics being located subdurally. Insulin infusion means are contemplated to respond manually or mechanically to information from the sensors through the CPU. Mechanical response may be automatic. Infusion means may be located subdurally. It is contemplated that the present invention enable revitalization or replacement of fluorescing compounds and glucose oxidase within the sensor assembly.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.